ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)

Clinical trial NCT02471391 · UNKNOWN

Trial details

NCT number: NCT02471391
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mantle Cell Lymphoma

Start date: 2015-07-22
Primary completion: 2020-11-20
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.